Medical device operating metrics: cross-company comparison

Reporting periods represented: Q1 2026, Q4 2026.

Context columns: share price and market value are from the latest recorded exchange data; LTM figures sum the issuer's last four quarterly filings and render blank unless all four quarters are on file; enterprise value = market value + total debt − cash from the latest quarterly balance sheet. These columns are sized context, not part of the SEC-exhibit extraction the table below is built from.

Metric coverage

• Segment revenue: 4 of 4 companies report this on the canonical basis.

Oxford Ledge Signal -- extracted from the issuer's own SEC earnings exhibit and normalized by Oxford Ledge. As reported by the issuer per regulatory convention, not re-audited by us; a figure our extractor could not verify is withheld, never shown. A metric is compared only across companies reporting it on the SAME basis and scope; a blank cell is an honest coverage gap, never a zero, and companies may report different quarters (see the period range). Source: each issuer’s own SEC EDGAR earnings exhibit.

Reporting periods represented: Q1 2026, Q4 2026.

Metric coverage

• Revenue growth: 4 of 4 companies report this on the canonical basis.

Oxford Ledge Signal -- extracted from the issuer's own SEC earnings exhibit and normalized by Oxford Ledge. As reported by the issuer per regulatory convention, not re-audited by us; a figure our extractor could not verify is withheld, never shown. A metric is compared only across companies reporting it on the SAME basis and scope; a blank cell is an honest coverage gap, never a zero, and companies may report different quarters (see the period range). Every figure in this table is a CHANGE the issuer reported for the period, not a level. Growth rates and levels never share a column or a table -- a change read as a level is a different number entirely. Source: each issuer’s own SEC EDGAR earnings exhibit.